✦ LIBER ✦

A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection

✍ Scribed by Barbara, L.; Mazzella, G.; Baraldini, M.; Gasbarrini, G.; Giungi, F.; Malavolti, M.; Mastroroberto, L.; Miglio, F.; Roda, E.; Raise, E.

Book ID: 123185878
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 218 KB
Volume: 3
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(86)80126-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lymphoblastoid interferon in controlled

Lymphoblastoid interferon in controlled trials of chronic hepatitis B virus infection

✍ Stephanos J. Hadziyannis 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB 👁 2 views

Preliminary report on randomised control

Preliminary report on randomised controlled trial of human lymphoblastoid interferon (LαIFN) in chronic b virus infection

📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 61 KB

A controlled trial of 6 months thrice we

A controlled trial of 6 months thrice weekly lymphoblastoid interferon versus no therapy in chronic hepatitis B virus infection

✍ Alexander, G.J.M.; Fagan, E.A.; Guarner, P.; Rolando, N.; Brahm, J.; Eddleston, 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 351 KB

A controlled trial of human lymphoblasto

A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy

✍ Giorgio Saracco; Giuseppe Mazzella; Floriano Rosina; Claudio Cancellieri; Valter 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB

A randomised controlled trial of recombi

A randomised controlled trial of recombinant interferon-γ in chinese patients with chronic hepatitis B virus infection

✍ Johnson Y. N. Lau; Dr. C. L. Lai; P. C. Wu; H. T. Chung; Anna S. F. Lok; H. J. L 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB

## Abstract Nineteen Chinese patients with chronic hepatitis B virus (HBV) infection, seropositive for HBV e antigen (HBeAg) and HBV DNA on at least three occasions in 6 months, were randomised to receive either recombinant human interferongamma (rlFNγ) 0.1 mg/m^2^ intramuscularly thrice weekly for

A randomised controlled trial of interfe

A randomised controlled trial of interferon alfa 2A for the treatment of chronic hepatitis B virus infection: Factor, that influence response

✍ Brook, MG; McDonald, JA; Karayiannis, P; Caruso, L; Forster, G; Harris, JRW; Tho 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 47 KB